Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience
Christoph Boss, Catherine Brisbare‐Roch, François Jenck
Journal of Medicinal Chemistry (2009) Vol. 52, Iss. 4, pp. 891-903
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Chemistry and Biology Of Multicomponent Reactions
Alexander Dömlingꝉ, Wei Wang, Kan Wang
Chemical Reviews (2012) Vol. 112, Iss. 6, pp. 3083-3135
Open Access | Times Cited: 2255
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell, Christopher J. Winrow
The Annual Review of Pharmacology and Toxicology (2011) Vol. 51, Iss. 1, pp. 243-266
Open Access | Times Cited: 350
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348
Hypocretin /orexin contributes to the expression of some but not all forms of stress and arousal
Teri M. Furlong, D.M.L. Vianna, Lu Liu, et al.
European Journal of Neuroscience (2009) Vol. 30, Iss. 8, pp. 1603-1614
Open Access | Times Cited: 165
Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 7931-7937
Closed Access | Times Cited: 109
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant
Petra Hoever, SL de Haas, Julia Winkler, et al.
Clinical Pharmacology & Therapeutics (2010) Vol. 87, Iss. 5, pp. 593-600
Closed Access | Times Cited: 101
Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
Cancer Research (2011) Vol. 71, Iss. 9, pp. 3341-3351
Open Access | Times Cited: 87
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
Efficient and Diverse Synthesis of Indole Derivatives
Haixia Liu, Alexander Dömlingꝉ
The Journal of Organic Chemistry (2009) Vol. 74, Iss. 17, pp. 6895-6898
Closed Access | Times Cited: 84
Polycyclic indole alkaloid-type compounds by MCR
Wei Wang, Eberhardt Herdtweck, Alexander Dömlingꝉ
Chemical Communications (2009) Vol. 46, Iss. 5, pp. 770-772
Closed Access | Times Cited: 71
Enantioselective Synthesis of a Dual Orexin Receptor Antagonist
Ian Mangion, Benjamin D. Sherry, Jingjun Yin, et al.
Organic Letters (2012) Vol. 14, Iss. 13, pp. 3458-3461
Closed Access | Times Cited: 70
Discovery of a Potent, CNS‐Penetrant Orexin Receptor Antagonist Based on an N,N‐Disubstituted‐1,4‐diazepane Scaffold that Promotes Sleep in Rats
David B. Whitman, Christopher D. Cox, Michael J. Breslin, et al.
ChemMedChem (2009) Vol. 4, Iss. 7, pp. 1069-1074
Closed Access | Times Cited: 70
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
The Ugi Three‐Component Reaction; a Valuable Tool in Modern Organic Synthesis
Nikolaos P. Tripolitsiotis, Maria Thomaidi, Constantinos G. Neochoritis
European Journal of Organic Chemistry (2020) Vol. 2020, Iss. 42, pp. 6525-6554
Closed Access | Times Cited: 46
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
John Gatfield, Catherine Brisbare‐Roch, François Jenck, et al.
ChemMedChem (2010) Vol. 5, Iss. 8, pp. 1197-1214
Closed Access | Times Cited: 65
Orexin receptor antagonists: a review of promising compounds patented since 2006
Paul J. Coleman, John J. Renger
Expert Opinion on Therapeutic Patents (2010) Vol. 20, Iss. 3, pp. 307-324
Closed Access | Times Cited: 60
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders
Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 18, pp. 5562-5567
Closed Access | Times Cited: 51
Synthesis of Tetrahydroisoquinoline Alkaloids and Related Compounds through the Alkylation of Anodically Prepared α-Amino Nitriles
Lotfi Benmekhbi, Fadila Louafi, Thierry Roisnel, et al.
The Journal of Organic Chemistry (2016) Vol. 81, Iss. 15, pp. 6721-6739
Closed Access | Times Cited: 38
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D. Cox, Georgia B. McGaughey, Michael J. Bogusky, et al.
Bioorganic & Medicinal Chemistry Letters (2009) Vol. 19, Iss. 11, pp. 2997-3001
Closed Access | Times Cited: 55
Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)
Pari Malherbe, Olivier Roche, Anne Marcuz, et al.
Molecular Pharmacology (2010) Vol. 78, Iss. 1, pp. 81-93
Closed Access | Times Cited: 45
Structure–Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT‐462206: a Potent, Brain‐Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Christoph Boss, Catherine Roch‐Brisbare, Michel A. Steiner, et al.
ChemMedChem (2014) Vol. 9, Iss. 11, pp. 2486-2496
Closed Access | Times Cited: 38
Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor
David A. Perrey, Nadezhda German, Brian P. Gilmour, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 17, pp. 6901-6916
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top